Similarly, our severe FSHD-like model shows mosaic DUX4-FL protein expression in myonuclei within several days of TMX administration (Figs 10 and 14 and S12 Fig). This evidence concerns the gene FLT3LG and facioscapulohumeral muscular dystrophy.